Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control.

@article{Meerleer2007IntensitymodulatedRT,
  title={Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control.},
  author={Gert O De Meerleer and Val{\'e}rie Fonteyne and Luc A M-L Vakaet and Geert Villeirs and Ludwig Denoyette and Antony C Verbaeys and Nicolas Lummen and Wilfried De Neve},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2007},
  volume={82 2},
  pages={160-6}
}
PURPOSE To report on late morbidity and biochemical relapse-free survival (bRFS) after intensity-modulated radiation therapy (IMRT) for prostate cancer. METHODS Between 1998 and 2005 133 patients were treated with IMRT for T(1-4) N0 M0 prostate cancer. The median follow-up time was 36 months. In a first cohort, patients received a median planning target volume (PTV) dose of 74 Gy with a hard constraint on maximum rectum dose of 72 Gy (74R72, n=51). Later, median PTV and maximum rectum dose… CONTINUE READING
39 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Similar Papers

Loading similar papers…